TrialThe lancet. Psychiatry2021

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.

Susan E Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.